Johnson & Johnson Common Stock (JNJ): Rumor News

JNJ – KraftHeinz said to be interested in a takeover of Colgate-Palmolive, along with Unilever and Johnson & Johnson.

Key Facts Surrounding This News Item

  • JNJ had a POWR Rating of A (Strong Buy) coming into today.
  • JNJ was 2.90% above its 10-Day Moving Average coming into today.
  • JNJ was 3.43% above its 20-Day Moving Average coming into today.
  • JNJ was 2.39% above its 50-Day Moving Average coming into today.
  • JNJ was 6.27% above its 100-Day Moving Average coming into today.
  • JNJ was 8.14% above its 200-Day Moving Average coming into today.
  • JNJ had returned +11.64% year-to-date leading up to today’s news, versus a +7.87% return from the benchmark S&P 500 during the same period.

More Info About Johnson & Johnson Common Stock (JNJ)

Johnson & Johnson researches and develops, manufactures, and sells various products in the health-care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. Some of its well-known brands include Tylenol-fever, Listerine-bad breath, Splenda-no-calorie sweetener, Neutrogena-skin care, Pepcid-heartburn, Zyrtec – allergy, Motrin-ibuprofen, Sudafed-allergy, and plenty more. The company was founded in 1885 and is based in New Brunswick, New Jersey. View our full JNJ ticker page with ratings, news, and more.

JNJ at a Glance

JNJ Current POWR Rating™
Overall POWR Rating™
JNJ Current Price $137.29 0.76%
More JNJ Ratings, Data, and News

JNJ Price Reaction

The day of this event (May. 17, 2017)
JNJ Closing Price$125.04 0.86%
JNJ Volume6,565,276
4.77% from avg
Leading up to this event
JNJ 1-mo return1.63%
After this event
JNJ 1-day return0.63%
JNJ 3-day return0.40%
JNJ 5-day return0.20%

JNJ Price Chart

More Johnson & Johnson Common Stock (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News
Page generated in 1.0963 seconds.